CEO Presentation at Onemed Forum
Sydney, Jan 13, 2015 AEST (ABN Newswire) - Rhinomed Ltd (
ASX:RNO) Rhinomed CEO Presentation at Onemed Forum.
WHO IS RHINOMED?
- A nasal and respiratory medical technology company based in Melbourne, Australia
- Rhinomed develops, markets and partners it's internal nasal technology platform into multiple form factors - internal nasal devices
- Focus is unmet needs in sport & exercise, sleep (snoring, sleep quality and sleep apnea), wellness and drug delivery
- Launched first product in February 2014, now shipping to 36 countries
- Second product released prior to Christmas
- Raised $7.5m to date
- Market Cap- AUD$13m, CY14 revenue - $527,000
- Listed: Australian Stock Exchange (ASX:RNO)
- Experienced Board and team including biotech execs and former European CEO of Nike
To view the presentation, including details on the benefits of the MuteSnoring and the Turbine products, please visit:
http://media.abnnewswire.net/media/en/docs/ASX-RNO-417694.pdf
About Rhinomed Limited
Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global
Follow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring
| ||
|
